Literature DB >> 2512680

Blood collection in strong acidic citrate anticoagulant used in a study of dietary influence on basal tPA activity.

M Rånby1, I B Sundell, T K Nilsson.   

Abstract

Tissue plasminogen activator (tPA) activity in blood and blood plasma has been difficult to determine because it is unstable, especially in subjects with high levels of plasminogen activator inhibitor type 1 (PAI-1). We have attempted to stabilize the tPA activity by collecting 9 volumes of blood in 1 volume acidic citrate buffer which immediately lowers the pH of the blood. At final blood pH of 4.9 to 6.3, consistent and high tPA activity levels were found. One acidic citrate buffer composition, 0.5 mol/l citrate buffer pH 4.0, resulted in final blood pH 5.5, tPA half-life of 10 days and an acceptably low degree of haemolysis. This anticoagulant composition was selected for more extensive evaluation and was used to collect blood plasma samples from 29 volunteers in the morning after a 10-minute bed rest. Basal tPA activity, mean and SD, was 0.47 +/- 0.21 IU/ml. After donating of the first blood sample, 10 of the volunteers entered into a 24-hour fast after which they donated a second sample. During the fast, the basal tPA activity increased from 0.34 +/- 0.21 to 0.47 +/- 0.23 IU/ml (p = 0.05) and the PAI-1 activity decreased from 11.4 +/- 11.6 to 6.3 +/- 8.9 U/ml (p = 0.04).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2512680

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease.

Authors:  F O Akenami; M Koskiniemi; M Färkkilä; A Vaheri
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

Review 2.  Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence.

Authors:  Douglas E Vaughan; Rahul Rai; Sadiya S Khan; Mesut Eren; Asish K Ghosh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06-01       Impact factor: 8.311

3.  Plasminogen Activator Inhibitor 1: Molecular Aspects and Clinical Importance.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

4.  Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients.

Authors:  Roberto Fogari; Paola Preti; Pierangelo Lazzari; Luca Corradi; Annalisa Zoppi; Elena Fogari; Amedeo Mugellini
Journal:  Eur J Clin Pharmacol       Date:  2003-06-27       Impact factor: 2.953

5.  Enalapril related changes in the fibrinolytic system in survivors of myocardial infarction.

Authors:  J H Jansson; K Boman; T K Nilsson
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  The influence of acute-phase levels of haemostatic factors on reperfusion and mortality in patients with acute myocardial infarction treated with streptokinase.

Authors:  Johan B Nilsson; Kurt Boman; Jan-Håkan Jansson; Torbjörn Nilsson; Ulf Näslund
Journal:  J Thromb Thrombolysis       Date:  2007-08-25       Impact factor: 2.300

7.  Peritoneal and systemic pH during pneumoperitoneum with CO2 and helium in a pig model.

Authors:  Maria Bergström; Peter Falk; Per-Ola Park; Lena Holmdahl
Journal:  Surg Endosc       Date:  2007-05-24       Impact factor: 4.584

8.  Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause.

Authors:  Johanna Gebhart; Sylvia Kepa; Stefanie Hofer; Silvia Koder; Alexandra Kaider; Alisa S Wolberg; Helmuth Haslacher; Peter Quehenberger; Ernst Eigenbauer; Simon Panzer; Christine Mannhalter; Ingrid Pabinger
Journal:  Ann Hematol       Date:  2016-12-26       Impact factor: 3.673

9.  Self-Reported Sitting Time, Physical Activity and Fibrinolytic and Other Novel Cardio-Metabolic Biomarkers in Active Swedish Seniors.

Authors:  Bethany J Howard; Anita Hurtig-Wennlöf; Lovisa A Olsson; Torbjörn K Nilsson; David W Dunstan; Patrik Wennberg
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

10.  Criteria and Search for Specific Assays for Active Plasminogen Activator Inhibitor 1 (PAI-1) in Plasma.

Authors:  C Kluft
Journal:  EJIFCC       Date:  2000-05-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.